Treatment options for refractory angina in patients who are not candidates for revascularization

被引:2
作者
Conti C.R. [1 ]
机构
[1] University of Florida, Health Science Center, Gainesville, FL 32610-0277
关键词
Coronary Artery Bypass Graft; Myocardial Ischemia; Stable Angina; Spinal Cord Stimulation; Ranolazine;
D O I
10.1007/s11886-006-0058-2
中图分类号
学科分类号
摘要
Patients with refractory angina are those for whom medical therapy has failed to eradicate the angina completely and who have persistent symptoms that are stable but limit their activities of daily living. Approach to management must include the elimination of the secondary causes of this condition and maximum medical therapy, and if angina persists, the consideration of other strategies. Controversy exists regarding the value of transmural myocardial laser revascularization. Enhanced external counterpulsation is clinically effective in approximately 70% of patients. Spinal cord stimulation is not being used clinically in the United States. In the United States, it is still an investigational procedure that is currently being evaluated prospectively in a randomized trial. Ranolazine, an inhibitor of sodium-dependent calcium overload, may prove to be useful in patients with refractory angina. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:272 / 276
页数:4
相关论文
共 50 条
  • [21] Interventional treatment of pain in refractory angina. A review
    Dobias, Milos
    Michalek, Pavel
    Neuzil, Petr
    Stritesky, Martin
    Johnston, Paul
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (04): : 518 - 527
  • [22] Spinal cord stimulation for the treatment of refractory angina pectoris
    Tykocki, Tomasz
    Guzek, Krystyna
    Mandat, Tomasz
    KARDIOLOGIA POLSKA, 2011, 69 (04) : 383 - 387
  • [23] Transcatheter treatment for refractory angina with the coronary sinus Reducer
    Konigstein, Maayan
    Meyten, Nathalie
    Verheye, Stefan
    Schwartz, Marc
    Banai, Shmuel
    EUROINTERVENTION, 2014, 9 (10) : 1158 - 1164
  • [24] Nonpharmacological interventions for 'no-option' refractory angina patients
    Paz, Yoav
    Levy, Yair
    Grosman-Rimon, Liza
    Shinfeld, Amihay
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (01) : 13 - 22
  • [25] Effectiveness of Enhanced External Counterpulsation Treatment on Symptom Burden, Medication Profile, Physical Capacity, Cardiac Anxiety, and Health-Related Quality of Life in Patients With Refractory Angina Pectoris
    Wu, Eline
    Desta, Liyew
    Brostrom, Anders
    Martensson, Jan
    JOURNAL OF CARDIOVASCULAR NURSING, 2020, 35 (04) : 375 - 385
  • [26] Therapeutic effect and safety of nicorandil in treatment of refractory angina pectoris
    Li, Ya
    Liu, Yongxing
    Peng, Wanzhong
    Wang, Bingxun
    Geng, Tao
    Xu, Zesheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (07): : 6993 - 6998
  • [27] Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal
    Thadani, Udho
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (17) : 2555 - 2563
  • [28] Oral sirolimus: A possible treatment for refractory angina pectoris in the elderly
    Mischie, Alexandru
    Chanseaume, Sylvain
    Gaspard, Philippe
    Andrei, Catalina Liliana
    Sinescu, Crina
    Schiariti, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 1097 - 1104
  • [29] Effect of Spinal Cord Stimulation in Patients With Refractory Angina: Evidence From Observational Studies
    Lanza, Gaetano Antonio
    Barone, Lucy
    Di Monaco, Antonio
    NEUROMODULATION, 2012, 15 (06): : 542 - 549
  • [30] Treatment options for angina pectoris and the future role of enhanced external counterpulsation
    Holmes, DR
    CLINICAL CARDIOLOGY, 2002, 25 (12) : 22 - 25